Association between serum gamma-glutamyltransferase and the progression of coronary artery calcification

Atherosclerosis

Volumn 243, Issue 1, 2015, Pages 300-306

  Cho, Yun Kyung ^a   Kang, Yu Mi ^a   Hwang, Jenie Yoonoo ^a   Kim, Eun Hee ^a   Yang, Dong Hyun ^a   Kang, Joon Won ^a   Park, Joong Yeol ^a   Lee, Woo Je ^a   Kim, Hong Kyu ^a   Jung, Chang Hee ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Coronary calcification; Coronary heart disease; Gamma glutamyltransferase; Progression

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; DIABETES MELLITUS; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MIDDLE AGED; PREDICTION; PREVALENCE; PRIORITY JOURNAL; AGED; BLOOD; BLOOD VESSEL CALCIFICATION; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BIOMARKERS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; VASCULAR CALCIFICATION;

EID: 84942456249     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.09.027     Document Type: Article

References (50)

1. Nemesanszky E., Lott J.A. Gamma-glutamyltransferase and its isoenzymes: progress and problems. Clin. Chem. 1985, 31:797-803.
2. Mao Y., Qi X., Xu W., et al. Serum gamma-glutamyl transferase: a novel biomarker for coronary artery disease. Med. Sci. Monit. 2014, 20:706-710.
3. Emdin M., Passino C., Michelassi C., Donato L., Pompella A., Paolicchi A. Additive prognostic value of gamma-glutamyltransferase in coronary artery disease. Int. J. Cardiol. 2009, 136:80-85.
4. Jiang S., Jiang D., Tao Y. Role of gamma-glutamyltransferase in cardiovascular diseases. Exp. Clin. Cardiol. 2013, 18:53-56.
5. Lee D.H., Jacobs D.R., Gross M., et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin. Chem. 2003, 49:1358-1366.
6. Wannamethee G., Ebrahim S., Shaper A.G. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am. J. Epidemiol. 1995, 142:699-708.
7. Bozbas H., Yildirir A., Karacaglar E., et al. Increased serum gamma-glutamyltransferase activity in patients with metabolic syndrome. Turk Kardiyol. Dern. Ars. 2011, 39:122-128.
8. Budoff M.J., Gul K.M. Expert review on coronary calcium. Vasc. Health. Risk Manag. 2008, 4:315-324.
9. Moon J.S., Yoon J.S., Won K.C., Cho I.H., Lee H.W. Diagnostic accuracy of 64-Slice MDCT coronary angiography for the assessment of coronary artery disease in korean patients with type 2 diabetes. Diabetes Metab. J. 2013, 37:54-62.
10. Silverman M.G., Blaha M.J., Krumholz H.M., et al. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the multi-ethnic study of atherosclerosis. Eur. Heart J. 2014, 35:2232-2241.
11. Budoff M.J., Hokanson J.E., Nasir K., et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc. Imaging 2010, 3:1229-1236.
12. Raggi P., Cooil B., Ratti C., Callister T.Q., Budoff M. Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus. Hypertension 2005, 46:238-243.
13. Atar A.I., Yilmaz O.C., Akin K., Selcoki Y., Er O., Eryonucu B. Association between gamma-glutamyltransferase and coronary artery calcification. Int. J. Cardiol. 2013, 167:1264-1267.
14. Bian L.Q., Zhang Z.Y., Kim S.J., Zhou C.C., Choi Y.H. Gamma glutamyltransferase as a novel marker of coronary artery calcification in women. J. Cardiovasc. Med. Hagerstown 2012, 13:684-690.
15. Carlson M.D., Morrison R.S. Study design, precision, and validity in observational studies. J. Palliat. Med. 2009, 12:77-82.
16. Jung C.H., Lee M.J., Kang Y.M., et al. The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation. J. Clin. Endocrinol. Metab. 2015, 100:934-941.
17. American Diabetes A Standards of medical care in diabetes-2015 abridged for primary care providers. Clin. Diabetes 2015, 33:97-111.
18. Furusyo N., Koga T., Ai M., et al. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia 2011, 54:3028-3036.
19. National Cholesterol Education Program Expert Panel on Detection E Treatment of high blood cholesterol in A. third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, 106. 3143-3421.
20. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004, 110:227-239.
21. Jung C.H., Lee M.J., Hwang J.Y., et al. Association of metabolically healthy obesity with subclinical coronary atherosclerosis in a Korean population. Obes. Silver Spring 2014, 22:2613-2620.
22. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 1990, 15:827-832.
23. Greenland P., LaBree L., Azen S.P., Doherty T.M., Detrano R.C. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004, 291:210-215.
24. Hokanson J.E., MacKenzie T., Kinney G., et al. Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. AJR Am. J. Roentgenol. 2004, 182:1327-1332.
25. Mehrotra R., Budoff M., Hokanson J.E., Ipp E., Takasu J., Adler S. Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int. 2005, 68:1258-1266.
26. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
27. Budoff M.J., Young R., Lopez V.A., et al. Progression of coronary calcium and incident coronary heart disease events: MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 2013, 61:1231-1239.
28. Arad Y., Goodman K.J., Roth M., Newstein D., Guerci A.D. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J. Am. Coll. Cardiol. 2005, 46:158-165.
29. Niccoli G., Della Bona R., Cosentino N., et al. Serum levels of γ-glutamyltransferase and progression of coronary atherosclerosis. Coron. Artery Dis. 2013, 24:40-47.
30. Ruttmann E., Brant L.J., Concin H., et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005, 112:2130-2137.
31. Jung C.H., Yu J.H., Bae S.J., et al. Serum gamma-glutamyltransferase is associated with arterial stiffness in healthy individuals. Clin. Endocrinol. Oxf. 2011, 75:328-334.
32. Whitfield J.B. Gamma glutamyl transferase. Crit. Rev. Clin. Lab. Sci. 2001, 38:263-355.
33. Paolicchi A., Minotti G., Tonarelli P., et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation-a potential mechanism in atherosclerosis. J. Investig. Med. 1999, 47:151-160.
34. Giral P., Ratziu V., Couvert P., et al. Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: relevance to oxidative stress. Atherosclerosis 2010, 210:607-613.
35. Paolicchi A., Emdin M., Ghliozeni E., et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 2004, 109:1440.
36. Maiolino G., Rossitto G., Caielli P., Bisogni V., Rossi G.P., Calo L.A. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediat. Inflamm. 2013, 2013:714653.
37. Shah N.R., Coulter S.A. An evidence-based guide for coronary calcium scoring in asymptomatic patients without coronary heart disease. Tex. Heart Inst. J. 2012, 39:240-242.
38. Mintz G.S., Pichard A.D., Popma J.J., et al. Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J. Am. Coll. Cardiol. 1997, 29:268-274.
39. Baumgart D., Schmermund A., Goerge G., et al. Comparison of electron beam computed tomography with intracoronary ultrasound and coronary angiography for detection of coronary atherosclerosis. J. Am. Coll. Cardiol. 1997, 30:57-64.
40. Budoff M.J., Achenbach S., Blumenthal R.S., et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American heart association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology. Circulation 2006, 114:1761-1791.
41. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., Schwartz R.S. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995, 92:2157-2162.
42. Georgiou D., Budoff M.J., Kaufer E., Kennedy J.M., Lu B., Brundage B.H. Screening patients with chest pain in the emergency department using electron beam tomography: a follow-up study. J. Am. Coll. Cardiol. 2001, 38:105-110.
43. Shaw L.J., Raggi P., Schisterman E., Berman D.S., Callister T.Q. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology 2003, 228:826-833.
44. Wayhs R., Zelinger A., Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J. Am. Coll. Cardiol. 2002, 39:225-230.
45. Lee W., Ryoo J.H., Suh B.S., Lee J., Kim J. Association of coronary artery calcification and serum gamma-glutamyl transferase in Korean. Atherosclerosis 2013, 226:269-274.
46. Gang L., Wei-Hua L., Rong A., Jian-Hong Y., Zi-Hua Z., Zhong-Zhi T. Serum gamma-glutamyltransferase levels predict the progression of coronary artery calcification in adults with type 2 diabetes mellitus. Angiology 2015, 66:667-674.
47. Cho H.S., Lee S.W., Kim E.S., et al. Clinical significance of serum bilirubin and gamma-glutamyltransferase levels on coronary atherosclerosis assessed by multidetector computed tomography. Nutr. Metab. Cardiovasc. Dis. 2015, 25:677-685.
48. Berry J.D., Liu K., Folsom A.R., et al. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atherosclerosis. Circulation 2009, 119:382-389.
49. Ozkok A., Caliskan Y., Sakaci T., et al. Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 2012, 7:965-973.
50. Vliegenthart R., Morris P.B. Computed tomography coronary artery calcium scoring: review of evidence base and cost-effectiveness in cardiovascular risk prediction. J. Thorac. Imaging 2012, 27:296-303.